Featured
Where From Here – Webinar Series
February 4: Last year saw unprecedented levels of cyber-privacy legislation, enforcement and malfeasance. 2021 promises no slowdown in this space. To help you and your team prepare, we discussed the digital transformation companies are experiencing due to Covid-19 and how to avoid the digital risks associated with this transformation.
Watch the webinar | View the slides | Get CLE Credit
January 28: Gia Lee, General Counsel at Clover Health, joined us for a discussion on the increasingly popular special purpose acquisition company (SPAC) transactions. We discussed Clover's SPAC journey and why they decided to go the SPAC route, what was most surprising about the process, and the key takeaways that came about during the deal. In addition, we addressed some of the common myths and provide the latest developments and market trends for 2021.
Watch the Webinar
January 21: 2020 showed record-setting sanctions with more guidance from regulators. It remains to be seen how the Biden Administration will prioritize and otherwise approach these complex matters. We discussed how the pandemic and other factors have changed the international trade and FCPA landscape. Listen to hear more about import and national security-related regimes, the global anti-corruption landscape, pandemic related fraud and compliance program expectations.
Watch the webinar | View the slides | Get CLE Credit
January 14: 2021 promises no slowdown in the novel employment questions coming at us. To help you and your team prepare, we discussed the key legal issues we expect employers will grapple with this year including; what to expect from the Biden Administration, including anticipated regulation, legislation and enforcement priorities, the COVID-19 vaccination landscape and what the latest stimulus package means for employers.
Watch the webinar | View the slides | Get CLE Credit
November 12: Our COVID-19 conversation series will take on a broader range of questions about the new normal. We will expand our focus at the same time that we continue to monitor and share best practices and updates in responding to the pandemic. That said, we kicked off with an update on C19, and were honored to be rejoined by Dr. Rachel Gordon, specialist in infectious diseases, Associate Professor of Medicine and Epidemiology, and Assistant Dean of Curricular Affairs at Columbia University Irving Medical Center. She provides medical insight into the pandemic and the new vaccine developments during a conversation with Orrick’s Lisa Lupion and Annette Hurst, who explain what this means for companies and the return to the workplace.
Watch the webinar | View the slides | Get CLE Credit
July 14: COVID-19 employment-related litigation is on the rise – are you prepared? Employers are confronting a rush of litigation raising novel theories and claims rarely if ever seen in employment matters. View our recent webinar in which our Employment Law team outlines key legal issues & themes, along with practical advice to help reduce the risk for your company.
Watch the webinar | View the slides | Get CLE Credit
June 17: Even before the onset of COVID-19, higher education institutions had generally been facing increased litigation activity, regulatory scrutiny, employment issues, and financial pressure due to decreased enrollment, while taking on more complicated and sophisticated financial transactions. COVID-19 has exacerbated these problems and brought on new ones such as negatively impacting endowments and investments in a material way and the onset of class action lawsuits relating to tuition refunds and other matters. To that end, Orrick’s Higher Education Focus Group, has assembled a panel for a special Orrick and Bond Buyer hosted webinar to both provide some market intelligence and educate higher education institutions on some of our thinking on these problems.
Watch the webinar | View the slides
June 4: Dr. Rachel Gordon, Director, Curricular Innovation and Strategic Initiatives for the Office of Education at the Columbia University Irving Medical Center and a specialist in infectious diseases, shares her perspective from a recent rotation in a COVID-19 unit. Dr. Gordon gives insight on the latest testing methods and best practices for the workplace while our team addresses the related legal considerations for companies as they prepare to return to the workplace.
Watch the webinar | View the slides | Get CLE Credit
COVID-19 US State Orders & Reopening Status
No statewide stay-at-home order; reopening in progress
Statewide stay-at-home order; reopening in progress
No statewide stay-at-home order; no reopening required
Last updated 2/25/2021. This map will be updated on a weekly basis.
You should independently confirm you have the latest order(s) before rendering any advice or making any decisions.
COVID-19 State Orders
Status of State Legislation
Status of US Courts
Q&As & Resources
Return to the Workplace
Employment – US | Employment – International | Privacy
Corporate Compliance & Contracts
Anti-Corruption & Compliance | Contracts/Force Majeure | Corporate Governance & Disclosure | Insurance | Tax
M&A and Strategic Collaborations
Mergers & Acquisitions | Antitrust
Finance, Government Relief & Restructuring
Restructuring | Paycheck Protection Program | CARES Act
Litigation & Enforcement
Status of US Courts
Return to the Workplace
- What are best practices for employers regarding coronavirus?
- What next when COVID-19 hits your global employee populations?
- As a U.S.-based organization, how does this impact my foreign national employees who are working pursuant to employment visas or permits?
- Can we ask non-employee visitors to take temperature tests at the entrance of our facilities?
- Can we ask non-employee visitors to make disclosures about recent travel and potential exposure prior to allowing entrance to our office?
Cybersecurity
Corporate Compliance & Contracts
- With COVID-19 impacting the movement of people and products, what anti-corruption and compliance risks should we keep in mind?
- How should companies address sales pressures from an anti-corruption and compliance perspective in this COVID-19 environment?
- What disclosure considerations should public companies be considering relating to COVID-19 impacts on their business?
- Are you facing pressure meeting your SEC filing deadlines because of facility shut-downs, work restrictions or employee absences relating to COVID-19?
- What to do if your supplier or customer is financially distressed?
- What if my contract does not have a force majeure clause?
- Does the COVID-19 pandemic constitute a force majeure event that excuses contractual performance?
- If we have closed our office and have people work from home, is there insurance available to cover lost productivity?
- If my major supplier’s operations are impacted or shutdown, do we have insurance for that impact on our business?
- Did the Internal Revenue Service Extend Tax Return Filing Deadlines and Defer Due Dates for 2019 Tax Payments Due to COVID-19?
- What are the employer tax credit provisions included in the Coronavirus Relief Bill?
M&A and Strategic Collaborations
Finance, Government Relief & Restructuring
Litigation & Enforcement
IP & Brand Protection
Municipal Finance
- Is a filing on EMMA required in connection with virus-related events, such as closures of facilities, reports of virus outbreaks or other actions?
- Many organizations eligible for tax-exempt financing are considering short-term taxable lines of credit, or increasing capacity under existing taxable lines of credit, in an effort to better manage cash flow in the coming months. Can organizations allocate draws on taxable lines of credit to capital expenditures and refinance such draws on a tax-exempt basis in the future?
State Regulation
Real Estate
Country Sites
Health Info
Contact
If you would like to speak to an Orrick lawyer about COVID-19-related questions, please contact us.
Sign up to receive
Orrick COVID-19 Alerts